The FDA approved the phase 2 Explore-OSA trial set to assess the highly selective aldosterone synthase inhibitor, ...

The FDA cleared the investigational new drug application for REC-4539, allowing for the start of a phase 1/2 trial in small ...

Chase Malackowski was diagnosed with Ewing's Sarcoma at eight years old. After trialing a "single patient Investigational New ...

The investigational new drug application for the nanoparticle drug SNB-101 has been cleared for small cell lung cancer ...

Celltrion, Inc. (068270.KS), a leading global biopharmaceutical company, today announced its innovative drug development ...

VisiRose Inc. ('VisiRose' or the 'Company'), a privately-held, clinical-stage biotechnology company developing novel ocular ...

AbbVie (NYSE: ABBV) and Simcere Zaiming, a subsidiary of Simcere Pharmaceutical Group Ltd (HKEX: 2096) today announced an option to license agreement to develop SIM0500, an investigational new drug ...

Solid Biosciences received clearance from the Food and Drug Administration for an investigational new drug application, the company said Tuesday.

New FDA draft guidance for drugmakers focuses on trial design for developing obesity treatments. Read more here.

Simcere Zaiming, a subsidiary of Simcere Pharmaceutical Group Ltd (HKEX: 2096) and AbbVie Inc. (NYSE: ABBV) today announced ...